OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Orthofix Medical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$9.59+0.21 (+2.24%)
Close on Oct 19, 2026
- Market cap
- $392.29M
- P/E (TTM)
- –
- Dividend yield
- –
Orthofix Medical Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Spine [Member] | $173.24M | $163.85M | $181.93M | $172.06M | $169.82M | $163.84M | $179.88M | $166.10M | $168.03M | $161.29M | $169.79M | $154.35M | 82.1% | +2.0% |
| Global Limb Reconstruction [Member] | $37.69M | $32.86M | – | – | $33.30M | $29.81M | – | – | – | – | – | – | 17.9% | +13.2% |
| Global Orthopedics [Member] | – | – | – | $33.57M | $33.30M | $29.81M | $35.77M | $30.50M | $30.59M | $27.32M | $30.63M | $29.65M | – | – |
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $170.03M | $161.33M | $180.31M | $170.34M | $171.74M | $161.68M | $179.22M | $166.64M | $166.93M | $160.02M | $166.91M | $153.25M | 80.6% | -1.0% |
| International [Member] | $40.90M | $35.38M | $39.61M | $35.29M | $31.38M | $31.97M | $36.43M | $29.97M | $31.69M | $28.59M | $33.51M | $30.76M | 19.4% | +30.3% |
| Others [Member] | $23.70M | $19.77M | $22.86M | $19.79M | $16.18M | $17.91M | $19.76M | $15.63M | $16.20M | $14.81M | $17.88M | $15.23M | 11.2% | +46.5% |
| Italy | $6.00M | $5.90M | $5.92M | $5.66M | $5.65M | $5.05M | $5.60M | $5.14M | $5.26M | $5.00M | $5.39M | $4.55M | 2.8% | +6.3% |
| United Kingdom | $3.69M | $3.87M | $3.53M | $3.65M | $3.12M | $3.04M | $2.99M | $2.94M | $2.62M | $2.63M | $2.66M | $2.93M | 1.8% | +18.5% |
| France | $3.27M | $2.63M | $3.46M | $2.69M | $3.18M | $2.63M | $4.36M | $3.00M | $3.51M | $2.52M | $2.89M | $2.93M | 1.5% | +2.6% |
| Germany | $2.32M | $2.17M | $2.32M | $2.31M | $2.27M | $2.21M | $2.34M | $2.17M | $2.39M | $2.11M | $2.84M | $3.27M | 1.1% | +2.2% |
| Brazil | $1.92M | $1.03M | $1.51M | $1.20M | $988.00K | $1.14M | $1.38M | $1.10M | $1.71M | $1.53M | $1.85M | $1.84M | 0.9% | +94.1% |
From the segment and revenue-disaggregation notes of Orthofix Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.